Population pharmacokinetics of theophylline. I: Intravenous infusion to children in the acute episode of asthma

I. Yano, Yusuke Tanigawara, M. Yasuhara, H. Mikawa, R. Hori

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The population pharmacokinetics of theophylline during constant-rate intravenous infusion has been studied in 66 children (8.7 ± 4.7 year of age; 26.0 ± 12.8 kg, mean ± S.D.) with an episode of acute asthma. One hundred and twelve theophylline serum concentrations (13.9 ± 4.8 μg/ml) collected retrospectively were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, age, gender, days after admission, blood gas measurements (PaO2, PaCO2, blood pH) and clinical analyses data (total serum protein, albumin concentration, haemoglobin concentration, haematocrit) on theophylline clearance was examined by the likelihood ratio test. A final estimate of population mean clearance was 58.6 ml/kg/h, which was decreased by 36% in patients with hepatic dysfunction. Other factors tested displayed no statistically significant effect on theophylline clearance. The inter-individual variability in clearance was 26% while the intra-individual variability in theophylline concentrations was 2.6 μg/ml as a standard deviation, which was almost double that observed for stable patients. Taking into account that the therapeutic window of this drug is 10-20 μg/ml, this value indicates a relatively large intra-individual variability and suggests that frequent (daily) monitoring of serum concentrations is necessary for patients with an episode of acute asthma.

Original languageEnglish
Pages (from-to)59-62
Number of pages4
JournalBiological and Pharmaceutical Bulletin
Volume16
Issue number1
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Theophylline
Intravenous Infusions
Asthma
Pharmacokinetics
Population
Liver
Serum
Hematocrit
Serum Albumin
Blood Proteins
Hemoglobins
Gases
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Population pharmacokinetics of theophylline. I : Intravenous infusion to children in the acute episode of asthma. / Yano, I.; Tanigawara, Yusuke; Yasuhara, M.; Mikawa, H.; Hori, R.

In: Biological and Pharmaceutical Bulletin, Vol. 16, No. 1, 1993, p. 59-62.

Research output: Contribution to journalArticle

@article{79f67668be334a239f7e0728975e02de,
title = "Population pharmacokinetics of theophylline. I: Intravenous infusion to children in the acute episode of asthma",
abstract = "The population pharmacokinetics of theophylline during constant-rate intravenous infusion has been studied in 66 children (8.7 ± 4.7 year of age; 26.0 ± 12.8 kg, mean ± S.D.) with an episode of acute asthma. One hundred and twelve theophylline serum concentrations (13.9 ± 4.8 μg/ml) collected retrospectively were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, age, gender, days after admission, blood gas measurements (PaO2, PaCO2, blood pH) and clinical analyses data (total serum protein, albumin concentration, haemoglobin concentration, haematocrit) on theophylline clearance was examined by the likelihood ratio test. A final estimate of population mean clearance was 58.6 ml/kg/h, which was decreased by 36{\%} in patients with hepatic dysfunction. Other factors tested displayed no statistically significant effect on theophylline clearance. The inter-individual variability in clearance was 26{\%} while the intra-individual variability in theophylline concentrations was 2.6 μg/ml as a standard deviation, which was almost double that observed for stable patients. Taking into account that the therapeutic window of this drug is 10-20 μg/ml, this value indicates a relatively large intra-individual variability and suggests that frequent (daily) monitoring of serum concentrations is necessary for patients with an episode of acute asthma.",
author = "I. Yano and Yusuke Tanigawara and M. Yasuhara and H. Mikawa and R. Hori",
year = "1993",
language = "English",
volume = "16",
pages = "59--62",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "1",

}

TY - JOUR

T1 - Population pharmacokinetics of theophylline. I

T2 - Intravenous infusion to children in the acute episode of asthma

AU - Yano, I.

AU - Tanigawara, Yusuke

AU - Yasuhara, M.

AU - Mikawa, H.

AU - Hori, R.

PY - 1993

Y1 - 1993

N2 - The population pharmacokinetics of theophylline during constant-rate intravenous infusion has been studied in 66 children (8.7 ± 4.7 year of age; 26.0 ± 12.8 kg, mean ± S.D.) with an episode of acute asthma. One hundred and twelve theophylline serum concentrations (13.9 ± 4.8 μg/ml) collected retrospectively were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, age, gender, days after admission, blood gas measurements (PaO2, PaCO2, blood pH) and clinical analyses data (total serum protein, albumin concentration, haemoglobin concentration, haematocrit) on theophylline clearance was examined by the likelihood ratio test. A final estimate of population mean clearance was 58.6 ml/kg/h, which was decreased by 36% in patients with hepatic dysfunction. Other factors tested displayed no statistically significant effect on theophylline clearance. The inter-individual variability in clearance was 26% while the intra-individual variability in theophylline concentrations was 2.6 μg/ml as a standard deviation, which was almost double that observed for stable patients. Taking into account that the therapeutic window of this drug is 10-20 μg/ml, this value indicates a relatively large intra-individual variability and suggests that frequent (daily) monitoring of serum concentrations is necessary for patients with an episode of acute asthma.

AB - The population pharmacokinetics of theophylline during constant-rate intravenous infusion has been studied in 66 children (8.7 ± 4.7 year of age; 26.0 ± 12.8 kg, mean ± S.D.) with an episode of acute asthma. One hundred and twelve theophylline serum concentrations (13.9 ± 4.8 μg/ml) collected retrospectively were analyzed using a nonlinear mixed-effect model. The influence of hepatic dysfunction, age, gender, days after admission, blood gas measurements (PaO2, PaCO2, blood pH) and clinical analyses data (total serum protein, albumin concentration, haemoglobin concentration, haematocrit) on theophylline clearance was examined by the likelihood ratio test. A final estimate of population mean clearance was 58.6 ml/kg/h, which was decreased by 36% in patients with hepatic dysfunction. Other factors tested displayed no statistically significant effect on theophylline clearance. The inter-individual variability in clearance was 26% while the intra-individual variability in theophylline concentrations was 2.6 μg/ml as a standard deviation, which was almost double that observed for stable patients. Taking into account that the therapeutic window of this drug is 10-20 μg/ml, this value indicates a relatively large intra-individual variability and suggests that frequent (daily) monitoring of serum concentrations is necessary for patients with an episode of acute asthma.

UR - http://www.scopus.com/inward/record.url?scp=0027460739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027460739&partnerID=8YFLogxK

M3 - Article

C2 - 8369754

AN - SCOPUS:0027460739

VL - 16

SP - 59

EP - 62

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 1

ER -